Document is current

Article History

Accepted: 21 March 2022

First Online: 27 April 2022

Declarations

:

: This paper received no funding.

: F.C. has no conflicts of interest or financial disclosures. H.Y. has previously served as a consultant for Supernus Pharmaceuticals, Inc. and Trillen Medical Inc, and currently receives research grants from NIH (R44NS115460). S.S. receives honoraria from Alder Biopharmaceuticals; Allergan, Inc.; Amgen; Avanir Pharmaceuticals, Inc.; Depomed; Dr. Reddy’s Laboratories; eNeura Inc.; electroCore Medical, LLC; Ipsen Biopharmaceuticals; Medscape, LLC; Medtronic, Inc.; Mitsubishi Tanabe Pharma America, Inc.; NINDS; St. Jude Medical; Supernus Pharmaceuticals, Inc.; Teva Pharmaceuticals and Trigemina, Inc.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: F.C. H.Y., and S.S. were involved in the design, writing, and revision of this article.